John Amerena

6.8k citations

95 papers · 2.2k indexed · 1 hit paper · h-index 24

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 1%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Blood Pressure and Hypertension Studies
- Acute Myocardial Infarction Research
- Cardiac Health and Mental Health
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in ⓘ

Cardiology and Cardiovascular Medicine 76
- Atrial Fibrillation Management and Outcomes 17
- Cardiac Health and Mental Health 15
- Blood Pressure and Hypertension Studies 14
- Acute Myocardial Infarction Research 14
- Heart Failure Treatment and Management 13
- Cardiovascular Function and Risk Factors 13
- Cardiac Arrhythmias and Treatments 12
Surgery 22

Co-authors: Stevo Julius (11 shared papers)Renato D. Lópes (4 shared papers)Lars Wallentin (4 shared papers)John H. Alexander (3 shared papers)Michael G. Hanna (2 shared papers)Stefan H. Hohnloser (2 shared papers)Mátyás Keltai (2 shared papers)Laine Thomas (2 shared papers)
Journals: The Medical Journal of Australia (10 papers)The American Journal of Cardiology (6 papers)Journal of Hypertension (4 papers)BMC Cardiovascular Disorders (4 papers)Hypertension (4 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

John Amerena

89 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial 2012 · 422 citations

Peers

Countries citing papers authored by John Amerena

Since Specialization

Citations

This map shows the geographic impact of John Amerena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Amerena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Amerena more than expected).

Fields of papers citing papers by John Amerena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Amerena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Amerena. The network helps show where John Amerena may publish in the future.

Co-authors

The 25 scholars most cited alongside John Amerena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Amerena Line = papers co-authored together John Amerena links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial European Heart Journal ·Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas, John H. Alexander, John Amerena, Michael G. Hanna, Mátyás Keltai, Fernando Laņas, Renato D. Lópes, José López‐Sendón, Christopher B. Granger, Lars Wallentin Hit paper breakdown →	2012	422
2	Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation Circulation Heart Failure ·John J.V. McMurray, Justin A. Ezekowitz, Basil S. Lewis, Bernard J. Gersh, Sean van Diepen, John Amerena, Jozef Bartúnek, Patrick Commerford, Byung‐Hee Oh, Veli‐Pekka Harjola, Sana M. Al‐Khatib, Michael G. Hanna, John H. Alexander, Renato D. Lópes, Daniel Wojdyla, Lars Wallentin, Christopher B. Granger	2013	113
3	The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Hypertension ·Stevo Julius, Michael A. Weber, Sverre E. Kjeldsen, Gordon T. McInnes, Alberto Zanchetti, Hans R. Brunner, John H. Laragh, M. Anthony Schork, Tsushung A. Hua, John Amerena, I Balažovjech, Graham Cassel, Béla Herczeg, Nevres Koylan, D Magometschnigg, Silja Majahalme, Felipe Martínez, W Oigman, Ricardo Seabra Gomes, Jun-ren Zhu	2006	108
4	Differences in management and outcomes for men and women with ST‐elevation myocardial infarction The Medical Journal of Australia ·Ehsan Khan, David Brieger, John Amerena, J. Atherton, Derek P. Chew, A. Farshid, Marcus Ilton, C. Juergens, Nadarajah Kangaharan, R. Rajaratnam, Amy Sweeny, D. Walters, Clara K Chow	2018	107
5	Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial BMJ ·Simon Stewart, M. Carrington, C. Swemmer, Craig S. Anderson, Nicol Kurstjens, John Amerena, Alex Brown, Louise M. Burrell, Ferdinandus J. de Looze, Mark Harris, Joseph Hung, Henry Krum, Mark Nelson, Markus P. Schlaich, Nigel Stocks, Garry Jennings, (unknown)	2012	87
6	Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation Journal of the American College of Cardiology ·Greg Flaker, Renato D. Lópes, Elaine M. Hylek, Daniel Wojdyla, Laine Thomas, Sana M. Al‐Khatib, Renee M. Sullivan, Stefan H. Hohnloser, David García, Michael Hanna, John Amerena, Veli-Pekka Harjola, Paul Dorian, Álvaro Avezum, Mátyás Keltai, Lars Wallentin, Christopher B. Granger	2014	81
7	Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial American Heart Journal ·Peter L. Thompson, Ian T. Meredith, John Amerena, Terence J. Campbell, J. G. Sloman, Phillip J. Harris	2004	76
8	Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) Trials ·Michael Clearfield, John Amerena, Jean‐Pierre Bassand, Hugo R Hernández García, Sam S. Miller, F. Sosef, Michael K. Palmer, Brian Bryzinski	2006	68
9	Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry The Medical Journal of Australia ·Derek P. Chew, John Amerena, S. Coverdale, Jamie Rankin, Carolyn Astley, Ashish Soman, David Brieger	2008	65
10	National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018 The Medical Journal of Australia ·David Brieger, John Amerena, John Attia, Beata Bajorek, Kim H. Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya Hall, Haris M. Haqqani, Jeroen Hendriks, Charlotte Hespe, Joseph Hung, Jonathan M. Kalman, Prashanthan Sanders, John Worthington, Tristan D. Yan, Nicholas Zwar	2018	64
11	The Role of the Autonomic Nervous System in Hypertension. Hypertension Research ·John Amerena, Stevo Julius	1995	57
12	SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial Coronary Artery Disease ·M. Yudi, David Clark, David Tsang, Michael Jelinek, Katie Kalten, S. Joshi, Khoa Phan, Jay Ramchand, Arthur Nasis, John Amerena, A. Koshy, A. Murphy, Sandeep Arunothayaraj, Si Si, Christopher M. Reid, Omar Farouque	2020	55
13	Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit Internal Medicine Journal ·Derek P. Chew, John Amerena, Steven Coverdale, James M. Rankin, Carolyn Astley, David Brieger	2007	52
14	Combating Inflammation in Cardiovascular Disease Heart Lung and Circulation ·A. Sethwala, Ian Y Goh, John Amerena	2020	41
15	Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension ·Kenneth Jamerson, S Smith, John Amerena, Eric J. Grant, Stevo Julius	1994	39
16	Angiotensin Mediates Forearm Glucose Uptake by Hemodynamic Rather Than Direct Effects Hypertension ·Kenneth Jamerson, Shawna D. Nesbitt, John Amerena, Eric J. Grant, Stevo Julius	1996	36
17	Efficacy and Feasibility of a Tele-health Intervention for Acute Coronary Syndrome Patients with Depression: Results of the “MoodCare” Randomized Controlled Trial Annals of Behavioral Medicine ·(unknown), Adrienne O’Neil, C. Barr Taylor, Kristy Sanderson, Sheila Cyril, Bianca Chan, Anna L. Hawkes, David L. Hare, Michael Jelinek, Kamalesh Venugopal, J. Atherton, John Amerena, Leeanne Grigg, D. Walters, Brian Oldenburg	2014	32
18	Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan Journal of Hypertension ·Shawna Smith, Stevo Julius, Kenneth Jamerson, John Amerena, Nicholas J. Schork	1994	31
19	Impact of Ethnicity on Left Ventricular Mass and Relative Wall Thickness in Essential Hypertension The American Journal of Cardiology ·Miguel Zabalgoitia, Syed N. Rahman, William E. Haley, Lori Oneschuk, Carla Yunis, Charles Lucas, Steven A. Yarows, Lisa Krause, John Amerena	1998	29
20	SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol BMC Cardiovascular Disorders ·M. Yudi, David Clark, David Tsang, Michael Jelinek, Katie Kalten, S. Joshi, Khoa Phan, Arthur Nasis, John Amerena, Sandeep Arunothayaraj, Chris Reid, Omar Farouque	2016	29

About John Amerena

John Amerena is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Complementary and alternative medicine, having authored 95 papers that have together received 2.2k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Health and Mental Health (15 papers), Cardiac Imaging and Diagnostics (14 papers), Blood Pressure and Hypertension Studies (14 papers), Acute Myocardial Infarction Research (14 papers), Heart Failure Treatment and Management (13 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac Arrhythmias and Treatments (12 papers). The work is most often cited by research in Internal Medicine (310 citations), Cardiology and Cardiovascular Medicine (1.7k citations), Endocrinology, Diabetes and Metabolism (239 citations), Surgery (362 citations) and Geriatrics and Gerontology (31 citations). John Amerena has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Stevo Julius, Renato D. Lópes, Lars Wallentin, John H. Alexander, Michael G. Hanna, Stefan H. Hohnloser, Mátyás Keltai, Laine Thomas, David Brieger and Fernando Laņas. Their work appears in journals such as The Medical Journal of Australia, The American Journal of Cardiology, Journal of Hypertension, BMC Cardiovascular Disorders and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact